| |
 |
ARTICLES 
|
|
| Adjuvant chemoendocrine therapy in breast cancer |
| G Bonadonna and P Valagussa |
|
JCO Apr 1 1986: 451–454.
[PDF]
|
 |
| Hodgkin's disease. IIB or not to be--using irradiation alone or in combination with chemotherapy? That is the question! |
| P Rubin, L Constine, and JM Bennett |
|
JCO Apr 1 1986: 455–457.
[PDF]
|
|
| WR-2721 protects against the hematologic toxicity of cyclophosphamide |
| TL Phillips |
|
JCO Apr 1 1986: 458.
[PDF]
|
|
|
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial |
| |
B Fisher, C Redmond, A Brown, ER Fisher, N Wolmark, D Bowman, D Plotkin, J Wolter, R Bornstein, and S Legault-Poisson |
| |
JCO Apr 1 1986: 459–471.
[Abstract]
[PDF]
|
|
|
Stage IIB Hodgkin's disease: the Stanford experience |
| |
MJ Crnkovich, RT Hoppe, and SA Rosenberg |
| |
JCO Apr 1 1986: 472–479.
[Abstract]
[PDF]
|
|
|
High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma |
| |
GL Phillips, RH Herzig, HM Lazarus, JW Fay, R Griffith, and GP Herzig |
| |
JCO Apr 1 1986: 480–488.
[Abstract]
[PDF]
|
|
|
Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia |
| |
P Benedetto, R Mertelsmann, TH Szatrowski, M Andreeff, T Gee, Z Arlin, S Kempin, and B Clarkson |
| |
JCO Apr 1 1986: 489–495.
[Abstract]
[PDF]
|
|
|
Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy |
| |
JS Loeffler, NJ Tarbell, H Kozakewich, JR Cassady, and HJ Weinstein |
| |
JCO Apr 1 1986: 496–501.
[Abstract]
[PDF]
|
|
|
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group Study |
| |
TP Miller, TT Chen, CA Coltman, Jr, RM O'Bryan, RB Vance, GB Weiss, WS Fletcher, RL Stephens, and RB Livingston |
| |
JCO Apr 1 1986: 502–508.
[Abstract]
[PDF]
|
|
|
Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center |
| |
R Pinzon, B Drewinko, JM Trujillo, V Guinee, and G Giacco |
| |
JCO Apr 1 1986: 509–514.
[Abstract]
[PDF]
|
|
|
Prognostic factors in advanced ovarian carcinoma |
| |
JR Redman, GR Petroni, PE Saigo, NL Geller, and TB Hakes |
| |
JCO Apr 1 1986: 515–523.
[Abstract]
[PDF]
|
|
|
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients |
| |
E Bork, M Hansen, P Dombernowsky, SW Hansen, AG Pedersen, and HH Hansen |
| |
JCO Apr 1 1986: 524–527.
[Abstract]
[PDF]
|
|
|
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer |
| |
Sr Loehrer PJ, LH Einhorn, and SD Williams |
| |
JCO Apr 1 1986: 528–536.
[Abstract]
[PDF]
|
|
|
Results of semen cryopreservation in young men with testicular carcinoma and lymphoma |
| |
E Reed, WG Sanger, and JO Armitage |
| |
JCO Apr 1 1986: 537–539.
[Abstract]
[PDF]
|
|
|
Human T-lymphotropic virus type III infection in previously immunocompromised hosts |
| |
JE Groopman, SM Hammer, SE Sallan, and JD Allan |
| |
JCO Apr 1 1986: 540–543.
[Abstract]
[PDF]
|
|
|
Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon |
| |
FX Real, HF Oettgen, and SE Krown |
| |
JCO Apr 1 1986: 544–551.
[Abstract]
[PDF]
|
|
|
A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations |
| |
F Gherlinzoni, G Bacci, P Picci, R Capanna, P Calderoni, EG Lorenzi, M Bernini, E Emiliani, E Barbieri, and A Normand |
| |
JCO Apr 1 1986: 552–558.
[Abstract]
[PDF]
|
|
|
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution |
| |
ME Horowitz, CB Pratt, BL Webber, HO Hustu, E Etcubanas, J Miliauskas, BN Rao, ID Fleming, AP Mahesh Kumar, and AA Green |
| |
JCO Apr 1 1986: 559–564.
[Abstract]
[PDF]
|
|
|
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association |
| |
F Richards, 2d, LD Case, DR White, HB Muss, CL Spurr, DV Jackson, MR Cooper, P Zekan, J Cruz, and JJ Stuart |
| |
JCO Apr 1 1986: 565–570.
[Abstract]
[PDF]
|
|
|
Neurotoxicity associated with systemic high-dose cytosine arabinoside |
| |
S Nand, HL Messmore, Jr, R Patel, SG Fisher, and RI Fisher |
| |
JCO Apr 1 1986: 571–575.
[Abstract]
[PDF]
|
|
|
Spinal computed tomography and computed tomographic metrizamide myelography in the early diagnosis of metastatic disease |
| |
T O'Rourke, CB George, J Redmond, 3d, H Davidson, P Cornett, WL Fill, DB Spring, D Sobel, IB Dabe, and RD Karl, Jr |
| |
JCO Apr 1 1986: 576–583.
[Abstract]
[PDF]
|
|
|
WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial |
| |
D Glover, JH Glick, C Weiler, S Hurowitz, and MM Kligerman |
| |
JCO Apr 1 1986: 584–588.
[Abstract]
[PDF]
|
|
|
13-cis retinoic acid treatment for myelodysplastic syndromes |
| |
VJ Picozzi, Jr, GF Swanson, R Morgan, F Hecht, and PL Greenberg |
| |
JCO Apr 1 1986: 589–595.
[Abstract]
[PDF]
|
|
|
Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system |
| |
S Strum, J McDermed, A Korn, and C Joseph |
| |
JCO Apr 1 1986: 596–603.
[Abstract]
[PDF]
|
|
|
A mastectomy--how so? An etymologic plea |
| |
RW MacMillan and JE Olson |
| |
JCO Apr 1 1986: 604–606.
[Abstract]
[PDF]
|
|
| Circadian CEA variability: when to sample |
| C Focan, D Focan-Henrard, MH Frere, SL Hung, V Castronovo, J Collette, P Franchimont, Y Touitou, F Levi, and R Roemeling |
|
JCO Apr 1 1986: 607–608.
[PDF]
|
|
| The 131I antiferritin breakthrough |
| CG Moertel |
|
JCO Apr 1 1986: 608–609.
[PDF]
|
|
| Consistent definitions of tumor response |
| SM Grunberg |
|
JCO Apr 1 1986: 609–610.
[PDF]
|
|
| Bone marrow transplantation for Hodgkin's disease |
| JA Russell, J Berry, WB Blahey, PH Geggie, B Houwen, AR Jones, MC Poon, and BA Ruether |
|
JCO Apr 1 1986: 610–611.
[PDF]
|
|
| High-dose melphalan and autologous bone marrow transplant as treatment for refractory Hodgkin's disease |
| PJ Selby, EK Mbidde, J Maitland, and TJ McElwain |
|
JCO Apr 1 1986: 612a.
[PDF]
|
|
| Management of patients with ovarian cancer |
| MH Tattersall and HJ Solomon |
|
JCO Apr 1 1986: 612b–614.
[PDF]
|
|
| Acute leukemia following cisplatin for bladder cancer |
| WB Bassett and RB Weiss |
|
JCO Apr 1 1986: 614.
[PDF]
|
|
